Covered Calls with Reinis Fischer

Share this post
Roll Forward and up 2 Covered Calls on Corbus Pharmaceuticals (NASDAQ:CRBP) - Potential income return 1.62% in 297 days
coveredcalls.reinisfischer.com

Roll Forward and up 2 Covered Calls on Corbus Pharmaceuticals (NASDAQ:CRBP) - Potential income return 1.62% in 297 days

Reinis Fischer
May 25, 2021
Share this post
Roll Forward and up 2 Covered Calls on Corbus Pharmaceuticals (NASDAQ:CRBP) - Potential income return 1.62% in 297 days
coveredcalls.reinisfischer.com

On May 21, 2021, we rolled forward and up 2 covered calls on CRBP stock with expiry on June 18, 2021. For this trade, we got a small $11 premium (after commissions).

This trade was originally established as a credit spread back on August 27, 2020, and since then we have been selling covered calls. Our average stock buys price $2.46

Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases by leveraging its pipeline of rationally designed, endocannabinoid system-targeting drug candidate.

Here is our trade setup:

  • SLD 2 CRBP JUNE 18 '21 2.5 Call Option 0.08 USD

what can happen next:

CRBP is trading below our strike price of $2.5 at the expiry date (June 8, 2021), in such case, we keep the premium and sell more covered calls to lower our cost basis.

In case CRBP is trading above our strike price of $2.5, our 200 shares get called away at the strike price of $2.5 and we realize our max gain of $9+ or  1.62% potential income in 297 days

Break-even: $1.92

Share this post
Roll Forward and up 2 Covered Calls on Corbus Pharmaceuticals (NASDAQ:CRBP) - Potential income return 1.62% in 297 days
coveredcalls.reinisfischer.com
Comments

Create your profile

0 subscriptions will be displayed on your profile (edit)

Skip for now

Only paid subscribers can comment on this post

Already a paid subscriber? Sign in

Check your email

For your security, we need to re-authenticate you.

Click the link we sent to , or click here to sign in.

TopNewCommunity

No posts

Ready for more?

© 2022 Reinis Fischer
Privacy ∙ Terms ∙ Collection notice
Publish on Substack Get the app
Substack is the home for great writing